Leprosy Mailing List – June 14, 2018
Ref.: (LML) Single-dose rifampicin chemoprophylaxis
From: Paul Saunderson, Ålesund, Norway
Dear Pieter,
Ben Naafs has flagged the letter written by Diana Lockwood and colleagues in PLoS NTDs, indicating their concerns about the promotion of single-dose rifampicin (SDR) for contacts of new cases, to prevent leprosy.
This debate has been going on for some months, and the forthcoming issue of Leprosy Review (June 2018) contains several relevant papers, including a very thoughtful Editorial by David Addiss of the Task Force for Global Health, entitled "Evidence, opportunity, ethics and the allure of zero leprosy."
The issue also contains the first interim report of the LPEP study, which will be of interest to many, as well as a letter from Professors Richardus and Smith about the misconceptions and misinterpretations that have arisen around the well-known COLEP study in Bangladesh, and which give rise to many of the criticisms being made by Lockwood et al.
Paul Saunderson,
Editor, Leprosy Review
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
No comments:
Post a Comment